Latest Form 4 insider transactions

Craig A. Anderson, SVP and Controller of Jackson Financial Inc., reported multiple transactions in common stock on September 24, 2026.

Leonard M Tannenbaum, a Director and 10% owner of Advanced Flower Capital Inc., purchased 25,228 shares of common stock on September 24, 2026.

Daniel J Nova, a Director of Harley-Davidson, Inc., reported multiple transactions in common stock on September 24, 2026.

Valmir Fernandes, Pr - Cinemark International of Cinemark Holdings, Inc., reported a transaction in 38,000 shares of common stock on September 25, 2026.

Adam Clammer, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

William R Shepard, a Director of Cme Group Inc., purchased 293 shares of common stock on September 25, 2026 for $268.76 per share.

Tco Group Holdings, L.P. reported changes in beneficial ownership of InnovAge Holding Corp. common stock on September 24, 2026.

Ignite Aggregator Lp and 5 others reported changes in beneficial ownership of InnovAge Holding Corp. common stock on September 24, 2026.

Jeffrey M Farber, Executive Vice President of Hanover Insurance Group, Inc., received 42 shares of common stock on September 25, 2026.

Jennifer Tejada, Executive Chair and a Director of PagerDuty, Inc., sold 8,000 shares of common stock on September 24, 2026 for $15.00 per share.

William D Green, a Director of Dell Technologies Inc., received 680 shares of common stock on September 24, 2026.

Nicholas Tzitzon, a Director of Acuity Brands Inc, received 296 shares of common stock on September 24, 2026.

Sanchez Oscar Iglesias, a Director of Codere Online Luxembourg, S.A., sold 460 shares of common stock on September 25, 2026 for $10.10 per share.

Peter Salovey, a Director of Legend Biotech Corp, received 28,330 shares of common stock on September 24, 2026.

Tomas J. Heyman, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Li Mao, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Patrick John Casey, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

Darren Xiaohui Ji, a Director of Legend Biotech Corp, received 28,330 shares of common stock on September 24, 2026.

Corazon (Corsee) D. Sanders, a Director of Legend Biotech Corp, received 20,986 shares of common stock on September 24, 2026.

David W Dorman, a Director of Dell Technologies Inc., received 633 shares of common stock on September 24, 2026.

Jean Jacques Bienaime, a Director of Ascendis Pharma A/S, reported multiple transactions in common stock on April 14, 2026.

Erica N. Truban, a Director of F&M Bank Corp, received 102 shares of common stock on September 24, 2026.

John R Palumbo, a Director of DarioHealth Corp., received 62,000 shares of common stock on September 24, 2026.

Adam K Stern, a Director of DarioHealth Corp., reported multiple transactions in common stock on September 18, 2025.

Dennis M Mcgrath, a Director of DarioHealth Corp., received 61,000 shares of common stock on September 24, 2026.

Yoav Shaked, a Director of DarioHealth Corp., reported multiple transactions in common stock on August 12, 2024.

Chen Franco-Yehuda, Chief Financial Officer of DarioHealth Corp., received 95,000 shares of common stock on September 24, 2026.

Fabiola R Arredondo, a Director of CAMPBELL'S Co, received 2,204 shares of common stock on September 25, 2026.

Kenneth C. Greenberg, a Director of Emmis Acquisition Corp., reported a transaction in 11,667 shares of common stock on September 25, 2026.

Dennis Matheis, a Director of DarioHealth Corp., received 44,000 shares of common stock on September 24, 2026.